This Article Full Text Full Text (PDF) All Versions of this Article: 34/4/982    most recent 01.STR.0000062902.94892.F5v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Song, H.-C. Articles by Kim, E. E. Search for Related Content PubMed PubMed Citation Articles by Song, H.-C. Articles by Kim, E. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYSTEINE METRONIDAZOLE Medline Plus Health Information Nuclear Scans Stroke Related Collections Acute Cerebral Infarction PET and SPECT

(Stroke. 2003;34:982.)
© 2003 American Heart Association, Inc.

Original Contributions

Prognostication of Recovery in Patients With Acute Ischemic Stroke Through the Use of Brain SPECT With Technetium-99m—Labeled Metronidazole

Ho-Chun Song, MD; Hee-Seung Bom, MD; Ki Hyun Cho, MD; Byeong Chae Kim, MD; Jeong-Jin Seo, MD; Chang-Guhn Kim, MD; David J. Yang, PhD E. Edmund Kim, MD

From the Departments of Nuclear Medicine (H-C.S., H-S.B.), Neurology (K.H.C., B.C.K.), and Diagnostic Radiology (J-J.S.), Chonnam National University Hospital, Gwangju, South Korea; Department of Nuclear Medicine (C-G.K.), Wonkwang University Hospital, Iksan, South Korea; and Department of Nuclear Medicine (D.J.Y., E.E.K.), University of Texas MD Anderson Cancer Center, Houston, Tex.

Correspondence to Hee-Seung Bom, MD, PhD, Department of Nuclear Medicine, Chonnam National University Hospital, 8 Hak-Dong, Dong-Gu, Gwangju 501-757, Korea. E-mail hsbom{at}chonnam.ac.kr

Background and Purpose— We hypothesized that technetium-99m-ethylene dicysteine-metronidazole (^99mTc-EC-MN) localizes to brain tissue that is hypoxic but viable. This study prospectively evaluated the relationship between neurological outcome and uptake of ^99mTc-EC-MN in peri-infarcted regions of the brain.

Methods— Eight patients with acute ischemic stroke in the territory of the left middle cerebral artery underwent ^99mTc-EC-MN and ^99mTc-ethyl cysteinate dimer (ECD) brain SPECTs on the same day during the subacute stage (10.3±2.5 days). The infarct volumes from ^99mTc-ECD images (IV_ECD), infarct volumes from diffusion-weighted MRI images (IV_DW), and hypoxic volume (HV) from ^99mTc-EC-MN images were calculated. The net infarct volume (NIV_ECD) was defined as IV_ECD minus HV. The National Institutes of Health Stroke Scale scores were measured on admission and days 1, 3, 7, and 30.

Results— IV_ECD was greater than IV_DW. The lesion-to-normal count-density ratios of ^99mTc-EC-MN ranged from 1.80 to 5.96. HV was 60.2±65.2 cm³, and the mean percent HV was 24.5±28.1% of IV_ECD. NIV_ECD was 162.6±133.4 cm³ and was significantly smaller than IV_ECD. NIV_ECD was significantly correlated with National Institutes of Health Stroke Scale score at 1 month and was a significant predictor of neurological deficit at 1 month.

Conclusions— ^99mTc-EC-MN brain SPECT can detect hypoxic tissue after acute ischemic stroke and, in combination with ^99mTc-ECD brain SPECT, is useful in predicting neurological outcome in ischemic stroke patients.

Key Words: cerebral infarction • metronidazole • prognosis • technetium compounds • tomography, emission computed

This article has been cited by other articles:

				M. Takasawa, R. R. Moustafa, and J.-C. Baron Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke Stroke, May 1, 2008; 39(5): 1629 - 1637. [Abstract] [Full Text] [PDF]

				S. K. Schiemanck, G. Kwakkel, M. W. M. Post, and A. J. H. Prevo Predictive Value of Ischemic Lesion Volume Assessed With Magnetic Resonance Imaging for Neurological Deficits and Functional Outcome Poststroke: A Critical Review of the Literature. Neurorehabil Neural Repair, December 1, 2006; 20(4): 492 - 502. [Abstract] [PDF]